Correction (DOI:10.1016/j.amjcard.2004.09.006);New predictors of outcome in idiopathic pulmonary arterial hypertension

American Journal of Cardiology

Volumn 95, Issue 2, 2005, Pages 199-203

  Kawut, Steven M ^a,c,d   Horn, Evelyn M ^a   Berekashvili, Ketevan K ^c   Garofano, Robert P ^b   Goldsmith, Rochelle L ^a   Widlitz, Allison C ^b   Rosenzweig, Erika B ^b   Kerstein, Diane ^b   Barst, Robyn J ^b  

^a Department of Internal Medicine ^*  (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c New York ^*  (United States)

^d Allergy Immunology and Asthma Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANOREXIGENIC AGENT; WARFARIN;

ADULT; AFRICAN AMERICAN; ALBUMIN BLOOD LEVEL; ARTICLE; ASIAN; BLOOD VESSEL REACTIVITY; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DRUG USE; FAMILIAL DISEASE; FEMALE; HEALTH CENTER; HEART INDEX; HIGH RISK POPULATION; HUMAN; IDIOPATHIC DISEASE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATIENT; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RACE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME;

EID: 11844268031     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.031     Document Type: Erratum

References (29)

1. G.E. D'Alonzo, R.J. Barst, S.M. Ayres, E.H. Bergofsky, B.H. Brundage, K.M. Detre, A.P. Fishman, R.M. Goldring, B.M. Groves, J.T. Kernis Survival in patients with primary pulmonary hypertension Results from a national prospective registry Ann Intern Med 115 1991 343 349
2. L.J. Rubin, D.B. Badesch, R.J. Barst, N. Galie, C.M. Black, A. Keogh, T. Pulido, A. Frost, S. Roux, I. Leconte, M. Landzberg, G. Simonneau Bosentan therapy for pulmonary arterial hypertension N Engl J Med 346 2002 896 903
3. G. Simonneau, R.J. Barst, N. Galie, R. Naeije, S. Rich, R.C. Bourge, A. Keogh, R. Oudiz, A. Frost, S.D. Blackburn, J.W. Crow, L.J. Rubin Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial Am J Respir Crit Care Med 165 2002 800 804
4. R.J. Barst, L.J. Rubin, W.A. Long, M.D. McGoon, S. Rich, D.B. Badesch, B.M. Groves, V.F. Tapson, R.C. Bourge A comparison of continuous intravenous epoprostenol with conventional therapy for primary pulmonary hypertension N Engl J Med 334 1996 296 302
5. G. Simonneau, N. Galie, L.J. Rubin, D. Langleben, W. Seeger, G. Domenighetti, S. Gibbs, D. Lebrec, R. Speich, M. Beghetti, S. Rich, A. Fishman Clinical classification of pulmonary hypertension J Am Coll Cardiol 43 2004 5S 12S
6. K. Nichols, R. Saouaf, A.A. Ababneh, R.J. Barst, M.S. Rosenbaum, M.W. Groch, A.H. Shoyeb, S.R. Bergmann Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imaging J Nucl Cardiol 9 2002 153 160
7. N. Galie, W. Seeger, R. Naeije, G. Simonneau, L.J. Rubin Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension J Am Coll Cardiol 43 suppl 2004 81S 88S
8. D.R. Cox Regression models and life tables (with discussion) J Royal Stat Soc 34 1972 187 220
9. P.M. Grambsch, T.M. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 1994 515 526
10. A.C. Justice, K.E. Covinsky, J.A. Berlin Assessing the generalizability of prognostic information Ann Intern Med 130 1999 515 524
11. H.J. Berger, R.A. Matthay, J. Loke, R.C. Marshall, A. Gottschalk, B.L. Zaret Assessment of cardiac performance with quantitative radionuclide angiocardiography: right ventricular ejection fraction with reference to findings in chronic obstructive pulmonary disease Am J Cardiol 41 1978 897 905
12. V.V. McLaughlin, A. Shillington, S. Rich Survival in primary pulmonary hypertension: the impact of epoprostenol therapy Circulation 106 2002 1477 1482
13. O. Sitbon, M. Humbert, H. Nunes, F. Parent, G. Garcia, P. Herve, M. Rainisio, G. Simonneau Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival J Am Coll Cardiol 40 2002 780 788
14. K.P. Kuhn, D.W. Byrne, P.G. Arbogast, T.P. Doyle, J.E. Loyd, I.M. Robbins Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol Am J Respir Crit Care Med 167 2003 580 586
15. R. Wensel, C.F. Opitz, S.D. Anker, J. Winkler, G. Hoffken, F.X. Kleber, R. Sharma, M. Hummel, R. Hetzer, R. Ewert Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing Circulation 106 2002 319 324
16. Kawut SM, Palevsky HI. Surrogate endpoints in pulmonary arterial hypertension. Am Heart J 2004;148:559-565.
17. S.M. Kawut, H.I. Palevsky New answers raise new questions in pulmonary arterial hypertension Eur Respir J 23 2004 799 801
18. A. Peacock, R. Naeije, N. Galie, J.T. Reeves End points in pulmonary arterial hypertension: the way forward Eur Respir J 23 2004 947 953
19. M.M. Hoeper, R.J. Oudiz, A. Peacock, V.F. Tapson, S.G. Haworth, A.E. Frost, A. Torbicki End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives J Am Coll Cardiol 43 suppl 2004 48S 55S
20. S. Rich, E. Kaufmann, P.S. Levy The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension N Engl J Med 327 1992 76 81
21. E.K. Weir, L.J. Rubin, S.M. Ayres, E.H. Bergofsky, B.H. Brundage, K.M. Detre, C.G. Elliott, A.P. Fishman, R.M. Goldring, B.M. Groves The acute administration of vasodilators in primary pulmonary hypertension Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension Am Rev Respir Dis 140 1989 1623 1630
22. O. Sitbon, M. Humbert, V. Ioos, X. Jais, F. Parent, G. Garcia, P. Herve, G. Simonneau Who benefits from long-term calcium-channel blocker therapy in primary pulmonary hypertension? (abstr) Am J Respir Crit Care Med 167 2004 A440
23. V. Fuster, P.M. Steele, W.D. Edwards, B.J. Gersh, M.D. McGoon, R.L. Frye Primary pulmonary hypertension: natural history and the importance of thrombosis Circulation 70 1984 580 587
24. M. Cohen, V. Fuster, W.D. Edwards Anticoagulation in the treatment of pulmonary hypertension A.P. Fishman The Pulmonary Circulation: Normal and Abnormal 1990 University of Pennsylvania Press Philadelphia, PA 501 510
25. H. Frank, J. Mlczoch, K. Huber, E. Schuster, H.P. Gurtner, M. Kneussl The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension Chest 112 1997 714 721
26. S.M. Kawut, D.B. Taichman, C.L. Archer-Chicko, H.I. Palevsky, S.E. Kimmel Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis Chest 123 2003 344 350
27. E. Bossone, G. Paciocco, D. Iarussi, A. Agretto, A. Iacono, B.W. Gillespie, M. Rubenfire The prognostic role of the ECG in primary pulmonary hypertension Chest 121 2002 513 518
28. D.E. Lilienfeld, L.J. Rubin Mortality from primary pulmonary hypertension in the United States, 1979-1996 Chest 117 2000 796 800
29. R. Cooper, J. Cutler, P. Desvigne-Nickens, S.P. Fortmann, L. Friedman, R. Havlik, G. Hogelin, J. Marler, P. McGovern, G. Morosco Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention Circulation 102 2000 3137 3147